Exciting addition for APHS and our ICON Division

APHS — Fri, 10 Jun 2011 02:30:31 +0000

Over the last couple of years APHS has developed a growing presence in the oncology sector. This is the direct result of an internal strategy we have been building under our ICON division (Integrated Clinical Oncology Network). The first phase of this strategy was to establish ourselves as a preeminent provider of pharmacy services for day oncology centres. The second phase was to secure partnerships with day oncology centres and thus participate in the delivery of direct cancer care. With that in mind I am delighted to announce we have an in-principle agreement to purchase a 75% stake in HOCA and provide long-term leadership under our ICON Division.

As Australia’s largest private oncology pharmacy service provider, APHS has a very sound understanding of the oncology industry. Our decision to diversify into direct patient care has grown out of a vision to provide comprehensive and holistic cancer care via a national network of day oncology clinics. Identifying partners that could lay a solid foundation on which to build this network was vital. With 4 day oncology hospitals and over 200 staff across south-east Queensland, HOCA is the largest private oncology provider in Australia and the perfect partner to kick off the second phase of our ICON strategy.

The agreement will see Dr Brett Robinson, CEO of APHS’ ICON Division, support HOCA’s senior leadership team to deliver a strong vision going forward.

APHS is currently completing due diligence, with the transaction expected to be complete in the next 3 months.

APHS » Oncology

Exciting addition for APHS and our ICON Division